Charles River Laboratories (CRL) Tops Q4 EPS by 6c; Guides FY16 EPS Above Consensus Midpoint
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts CRL Hot Sheet
Price: $345.37 +1.68%
Revenue Growth %: -4.0%
Financial Fact:
Continuing operations (in dollars per share): 0.79
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Revenue Growth %: -4.0%
Financial Fact:
Continuing operations (in dollars per share): 0.79
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Join SI Premium – FREE
Charles River Laboratories (NYSE: CRL) reported Q4 EPS of $1.00, $0.06 better than the analyst estimate of $0.94. Revenue for the quarter came in at $353.9 million versus the consensus estimate of $349.2 million.
GUIDANCE:
2016 GUIDANCE EXCLUDING WIL RESEARCH | |||
(from continuing operations) | |||
| Revenue growth, reported | 8% - 10% | ||
| Negative impact of foreign exchange | (~1%) | ||
| Revenue growth, constant currency | 9% - 11% |
Charles River Laboratories sees FY2016 EPS of $4.07-$4.17, versus the consensus of $4.16.
For earnings history and earnings-related data on Charles River Laboratories (CRL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
- Tompkins Financial (TMP) Tops Q3 EPS by 5c
- First Hawaiian (FHB) Misses Q3 EPS by 7c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
